Wells Fargo’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Wells Fargo’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,109	Closed	-$1.12K	–	7862
2022 Q4	$1.12K	Sell	10,109 -497	-5%	-$317	﹤0.01%	6147
2022 Q3	$11K	Sell	10,606 -3,958	-27%	-$9.02K	﹤0.01%	5672
2022 Q2	$27K	Sell	14,564 -10,644	-42%	-$25.9K	﹤0.01%	5309
2022 Q1	$90K	Sell	25,208 -55,179	-69%	-$271K	﹤0.01%	5381
2021 Q4	$692K	Sell	80,387 -494	-0.6%	-$3.14K	﹤0.01%	4412
2021 Q3	$614K	Sell	80,881 -273	-0.3%	-$2.3K	﹤0.01%	4543
2021 Q2	$538K	Buy	81,154 +63,665	+364%	+$401K	﹤0.01%	4579
2021 Q1	$211K	Buy	+17,489	New	+$347K	﹤0.01%	5127

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Wells Fargo's LHDX Position: Q1 2023 in Review

Wells Fargo sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 10,109 shares — an estimated $1.12K sold.

Wells Fargo first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $692K in Q4 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

Wells Fargo reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Wells Fargo sold 10,109 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $1.12K.
Wells Fargo first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Wells Fargo's Lucira Health, Inc. Common Stock position peaked at $692K in Q4 2021.
6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.